CIBC Asset Management’s West Pharmaceutical WST Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.2M Sell
10,033
-897
-8% -$196K 0.01% 555
2025
Q1
$2.45M Sell
10,930
-128
-1% -$28.7K 0.01% 539
2024
Q4
$3.62M Buy
11,058
+477
+5% +$156K 0.01% 465
2024
Q3
$3.18M Buy
10,581
+762
+8% +$229K 0.01% 490
2024
Q2
$3.23M Sell
9,819
-655
-6% -$216K 0.01% 447
2024
Q1
$4.14M Buy
10,474
+316
+3% +$125K 0.01% 419
2023
Q4
$3.58M Sell
10,158
-451
-4% -$159K 0.01% 423
2023
Q3
$3.98M Buy
10,609
+30
+0.3% +$11.3K 0.02% 393
2023
Q2
$4.05M Sell
10,579
-105
-1% -$40.2K 0.02% 403
2023
Q1
$3.7M Buy
10,684
+228
+2% +$79K 0.01% 421
2022
Q4
$2.46M Buy
10,456
+727
+7% +$171K 0.01% 493
2022
Q3
$2.39M Buy
9,729
+736
+8% +$181K 0.01% 485
2022
Q2
$2.72M Sell
8,993
-2,821
-24% -$853K 0.01% 437
2022
Q1
$4.85M Sell
11,814
-2,251
-16% -$924K 0.02% 365
2021
Q4
$6.6M Buy
14,065
+286
+2% +$134K 0.02% 331
2021
Q3
$5.85M Sell
13,779
-414
-3% -$176K 0.02% 320
2021
Q2
$5.1M Buy
14,193
+1,091
+8% +$392K 0.02% 350
2021
Q1
$3.69M Buy
13,102
+678
+5% +$191K 0.02% 376
2020
Q4
$3.52M Buy
12,424
+455
+4% +$129K 0.02% 362
2020
Q3
$3.29M Buy
11,969
+5,681
+90% +$1.56M 0.02% 335
2020
Q2
$1.43M Buy
6,288
+3,577
+132% +$812K 0.01% 489
2020
Q1
$413K Hold
2,711
﹤0.01% 663
2019
Q4
$408K Buy
2,711
+71
+3% +$10.7K ﹤0.01% 773
2019
Q3
$374K Hold
2,640
﹤0.01% 766
2019
Q2
$330K Hold
2,640
﹤0.01% 819
2019
Q1
$291K Hold
2,640
﹤0.01% 849
2018
Q4
$259K Hold
2,640
﹤0.01% 828
2018
Q3
$326K Hold
2,640
﹤0.01% 822
2018
Q2
$262K Buy
2,640
+172
+7% +$17.1K ﹤0.01% 889
2018
Q1
$218K Hold
2,468
﹤0.01% 943
2017
Q4
$244K Hold
2,468
﹤0.01% 905
2017
Q3
$238K Buy
2,468
+106
+4% +$10.2K ﹤0.01% 890
2017
Q2
$223K Buy
+2,362
New +$223K ﹤0.01% 883
2017
Q1
Sell
-2,362
Closed -$200K 985
2016
Q4
$200K Buy
+2,362
New +$200K ﹤0.01% 907
2015
Q3
Sell
-4,954
Closed -$288K 969
2015
Q2
$288K Buy
4,954
+8
+0.2% +$465 ﹤0.01% 802
2015
Q1
$298K Buy
4,946
+131
+3% +$7.89K ﹤0.01% 787
2014
Q4
$256K Buy
+4,815
New +$256K ﹤0.01% 804